Corrigendum: Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
Main Authors: | Xu Guo, Ning Ma, Feng Gao, Da-Peng Mo, Gang Luo, Zhong-Rong Miao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.673264/full |
Similar Items
-
Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
by: Xu Guo, et al.
Published: (2021-01-01) -
Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
by: Haowen Xu, et al.
Published: (2020-08-01) -
Neuroform EZ Stenting for Symptomatic Intracranial Artery Stenosis: 30 Days Outcomes in a High-Volume Stroke Center
by: Haowen Xu, et al.
Published: (2019-05-01) -
Intracranial Stenting: Is It Still an Option for Treatment of Patients With Intracranial Atherosclerosis?
by: Ahmed Abualhasan, et al.
Published: (2019-11-01) -
Risk factors of in⁃stent restenosis for intracranial artery stenosis: a Meta⁃analysis
by: Qian LI, et al.
Published: (2018-03-01)